期刊文献+

直肠癌根治性前切除后复发转移的危险因素 被引量:1

Risk factors for recurrence and metastasis after radical anterior resection for rectal cancer
原文传递
导出
摘要 目的研究直肠癌根治性前切除后复发转移的危险因素。方法回顾性分析1983-2000年间单个医疗机构直肠癌根治性前切除的957例患者的临床资料,分析复发转移的危险因素。结果共计有150例患者(15.7%)复发转移,复发转移部位依次为盆腔内局部复发57例(6.0%)、肝脏转移47例(4.9%)、肺部转移40例(4.2%)和其他部位转移6例(0.6%),中位复发转移时间18个月(2-85个月)。复发转移后中位生存8个月(1-62个月)。23例患者(15.3%)切除了肿瘤,术后中位生存30个月,生存超过5年者只有3例(13.0%)。低龄(P=0.024)、有肿瘤家族史(P=0.000)、癌胚抗原(CEA)水平(P=0.003)、肿瘤浸透肌层(P=0.000)、淋巴结转移(P=0.000)、脉管瘤栓(P=0.000)、印戒细胞癌或黏液腺癌(P=0.000)显著增加复发转移的风险。Logistic回归分析发现,肿瘤家族史(P=0.001)、CEA阳性(P=0.033)、肿瘤浸透肌层(P=0.000)、淋巴结转移(P=0.000)、脉管瘤栓(P=0.001)、印戒细胞癌或者黏液腺癌(P=0.012)是有显著统计学意义的复发转移的危险因素。结论直肠癌根治性前切除后存在特定的复发转移危险因素。盆腔、肝脏和肺是肿瘤复发转移的主要部位。 Objective To investigate the risk factors for local recurrence and distant metastasis after radical anterior resection for rectal cancer. Methods Clinieopathological data of 957 patients who underwent radical anterior resection for rectal cancer from 1983 to 2000 were reviewed retrospectively. The risk factors for local recurrence and distant metastasis were analyzed. Results There were 150 recurrent or metastatic cases (15. 7% ) after radical resection during a median follow-up of 71 months. Recurrence and metastasis sites included pelvies(6. 0%, n=57), liver(4. 9%, a =47), lung(4.2%, n =40) and other sites (0. 6%, a =6). The median recurrent interval was 18months(2 -85 months), with a median survival of 8 months (1-62 months) after recurrence. Re-resection of the tumors was performed in 23 patients (15.3%), and the median survival of such patients was 30 months with a S-year survival rate of 13.0%. There, were significant differences in recurrence and metastasis considering age, family history of tumor, CEA level, T staging, lymph node metastasis, venous cancerous emboli and signet cell carcinoma or mucinous Logistic regression analysis revealed that family history ( P = 0. 001 ), high CEA level ( P = 0. 033 ), T3-4 ( P = 0. 000), lymph node metastasis ( P = 0. 000), venous cancerous emboli ( P = 0. 001 ), and signet cell carcinoma or mucinous adenocarcinoma ( P = 0. 012) were risk factors for recurrence and metastasis. Conclusions There are several risk factors for recurrence after radical anterior resection for rectal cancer. The main recurrent or metastatic sites are pelvis, liver and lung. Resection of recurrent tumor can prolong the survival.
出处 《中华胃肠外科杂志》 CAS 2006年第3期210-213,共4页 Chinese Journal of Gastrointestinal Surgery
关键词 直肠肿瘤 根治性前切除 全直肠系膜切除 复发转移 预后 Rectal neoplasms Radical anterior resection Total mesorectal excision Neoplasms recurrence, local Distant metastasis Prognosis
  • 相关文献

参考文献8

  • 1Moriya Y,Akasu T,Fujita S,et al.Total pelvic exenteration with distal sacrectomy for fixed recurrent rectal cancer.Surg Oncol Clin N Am,2005,14:225-238.
  • 2Hemminki K,Li X,Dong C.Second primary cancers after sporadic and familial colorectal cancer.Cancer Epidemiology,Biomarkers & Prevention,2001,10:793-798.
  • 3Johns LE,Kee F,Collins BJ,et al.Colorectal cancer mortality in first-degree relatives of early-onset colorectal cancer cases.Dis Colon Rectum,2002,45:681-686.
  • 4Weitz J,Koch M,Debus J,et al.Colorectal cancer.Lancet,2005,365:153-165.
  • 5Heald RJ,Husband EM,Ryall RDH,et al.Recurrence and survival after total mesorectal excision for rectal cancer.Lancet,1986,1:1479-1482.
  • 6Wibe A,Moller B,Norstein J,et al.A national strategic change in treatment policy for rectal cancer-implementation in Norway:A national audit.Dis Colon Rectum,2002,45:857-866.
  • 7Kane JM,Petrelli NJ.Controversies in the surgical management of rectal cancer.Sem Radiation Oncol,2003,13:403-418.
  • 8赵东兵,邵永孚.全国结直肠癌氟尿嘧啶门静脉插管化疗预后分子机制的研究[J].中华胃肠外科杂志,2005,8(3):273-274. 被引量:2

二级参考文献10

  • 1Vogelstein B,Fearon ER,Kern SE,et al. Allelotype of colorectal carcinomas. Science,1989,244:207- 211.
  • 2Jen J,Kim H,Piantadosi S,et al. Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med,1994,331:213- 221.
  • 3Purdie CA. 17q allele loss is associated with lymph node metastasis in locally aggressive human colorectal cancer. J Pathol,1995,175:297- 302.
  • 4Andreyev HJ,Norman AR,Cunningham D,et al. Kirsten ras mutations in patients with colorectal cancer:the multicenter " RASCAL" study. J Natl Cancer Inst,1998,90:675- 684.
  • 5Shibata D,Reale MA,Lavin P,et al. The DCC protein and prognosis in colorectal cancer. N Engl J Med,1996,335:1727- 1732
  • 6Sankila R,Aaltonen LA,J rvinen HJ,et al. Better survival rates in patients with MLH1- associated hereditary colorectal cancer. Gastroenterology,1996,110:682- 687.
  • 7Bubb VJ,Curtis LJ,Cunningham C,et al. microsatellite instability and the role of Hmsh2 in sporadic colorectal cancer. Oncogene,1996,12:2641- 2649.
  • 8Johnston PG,Lenz HJ,Leichman CG,et al. Thymidylate synthase gene and protein expression correlate and are associated wit response to 5- fluorouracil in human colorectal and gastric tumors. Cancer Res,1995,55:1407- 1412.
  • 9Popat S,Matakidou A,Houston RS. Thymidylate synthase expression and prognosis in colorectal cancer:a systematic review and meta- analysis. J Clin Oncol,2004,22:529- 536.
  • 10邵永孚,赵东兵.全国大肠癌5-Fu门静脉插管化疗研究进展[J].浙江肿瘤,1999,5(2):67-68. 被引量:1

共引文献1

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部